Bharat Biotech will pay a royalty of 5% on the net sales of Covaxin, its Covid-19 vaccine, to Indian Council of Medical Research (ICMR).This has prompted public health and intellectual property experts to voice concerns.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3C4kQFA
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» 5% of Covaxin royalty to ICMR raises questions
https://ift.tt/eA8V8J
No comments:
Post a Comment